Testing active choice for screening practitioner's gender in endoscopy among disinclined women: An online experiment.
Decision making
attitude change
cancer screening
endoscopist gender
gender preferences
online experiment
Journal
Journal of medical screening
ISSN: 1475-5793
Titre abrégé: J Med Screen
Pays: England
ID NLM: 9433359
Informations de publication
Date de publication:
06 2019
06 2019
Historique:
pubmed:
16
11
2018
medline:
30
5
2020
entrez:
16
11
2018
Statut:
ppublish
Résumé
A large proportion of women have a preference for a same-gender endoscopy practitioner. We tested how information about practitioner gender affected intention to have bowel scope screening in a sample of women disinclined to have the test. In an online experimental survey, women aged 35-54 living in England who did not intend to participate in bowel scope screening (N = 1060) were randomised to one of four experimental conditions: (1) control (practitioner's gender is unknown), (2) opposite-gender (male practitioner by default), (3) same gender (female practitioner by default), and (4) active choice (the patient could choose the gender of the practitioner). Intention was measured following the interventions. Of 1010 (95.3%) women who completed the survey, most were White-British (83.6%), and working (63.3%). Compared with control, both active choice and same-gender conditions increased intention among disinclined women (9.3% vs. 16.0% and 17.9%; OR: 1.85; 95% CI: 1.07-3.20 and OR: 2.07; 95% CI: 1.23-3.50). There were no differences in intention between the opposite-gender and control conditions (9.8% vs. 9.3%; OR: 1.06; 95% CI: 0.60-1.90) or the active choice and same-gender conditions (16.0% vs. 17.9%: OR: 0.89; 95% CI: 0.55-1.46, using same gender as baseline). Offering disinclined women a same-gender practitioner, either by choice or default, increased subsequent intention, while an opposite gender default did not negatively affect intention. Reducing uncertainty about gender of practitioner could positively affect uptake in women, and should be tested in a randomised controlled trial.
Identifiants
pubmed: 30428750
doi: 10.1177/0969141318806322
pmc: PMC6484820
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
98-103Subventions
Organisme : Cancer Research UK
ID : 14134
Pays : United Kingdom
Références
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Gastrointest Endosc. 2005 Aug;62(2):219-23
pubmed: 16046982
J Med Screen. 2016 Jun;23(2):77-82
pubmed: 26387824
Gastrointest Endosc. 2002 Aug;56(2):170-3
pubmed: 12145592
Endoscopy. 2000 Jun;32(6):481-2
pubmed: 10863917
Lancet. 2010 May 8;375(9726):1624-33
pubmed: 20430429
J Med Screen. 2005;12(1):20-7
pubmed: 15814015
Int J Epidemiol. 2011 Jun;40(3):712-8
pubmed: 21330344
Br J Cancer. 2016 Mar 29;114(7):751-8
pubmed: 26977856
Am J Gastroenterol. 2004 Feb;99(2):341-9
pubmed: 15046227